Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-22-045358

Chief Executive Officer bought 3,800 shares at $0.26 ($1,003)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Yuval Chief Executive Officer 2022-08-10 Purchase +3,800 $0.26 $1,003 98,230 D: show line 1 in the form
Open-market purchases · 3,800 sh · avg $0.26 · $1,003
Loading xslF345X03/doc4.xml…